Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,627,106
  • Shares Outstanding, K 386,623
  • Annual Sales, $ 3,236 M
  • Annual Income, $ -3,561 M
  • EBIT $ -3,945 M
  • EBITDA $ -3,851 M
  • 60-Month Beta 1.86
  • Price/Sales 3.88
  • Price/Cash Flow N/A
  • Price/Book 1.15

Options Overview Details

View History
  • Implied Volatility 64.82% ( +0.20%)
  • Historical Volatility 70.52%
  • IV Percentile 54%
  • IV Rank 45.16%
  • IV High 92.67% on 12/18/24
  • IV Low 41.88% on 05/17/24
  • Put/Call Vol Ratio 1.01
  • Today's Volume 43,323
  • Volume Avg (30-Day) 75,799
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 888,782
  • Open Int (30-Day) 858,877

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -2.90
  • Number of Estimates 10
  • High Estimate -1.26
  • Low Estimate -3.64
  • Prior Year -3.07
  • Growth Rate Est. (year over year) +5.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.35 +11.28%
on 03/04/25
38.12 -14.32%
on 03/13/25
-2.87 (-8.08%)
since 02/21/25
3-Month
29.25 +11.66%
on 02/14/25
48.92 -33.24%
on 01/07/25
-6.73 (-17.09%)
since 12/20/24
52-Week
29.25 +11.66%
on 02/14/25
170.47 -80.84%
on 05/24/24
-71.43 (-68.62%)
since 03/21/24

Most Recent Stories

More News
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Valuation always matters in investing. And sometimes you can find stocks that are especially great bargains.

ALT : 5.81 (+0.52%)
MRNA : 32.66 (+0.65%)
PFE : 26.28 (+0.34%)
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

SRPT : 74.10 (+0.88%)
BMRN : 71.24 (-0.50%)
GILD : 107.08 (+1.14%)
MRNA : 32.66 (+0.65%)
AMGN : 316.04 (+0.32%)
4 Things You Need to Know if You Buy Moderna Stock Today

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020. Despite...

MRNA : 32.66 (+0.65%)
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

BMRN : 71.24 (-0.50%)
VRTX : 503.20 (-1.37%)
MRNA : 32.66 (+0.65%)
UTHR : 312.99 (-0.19%)
BIIB : 140.90 (-0.34%)
2 No-Brainer Biotech Stocks to Buy Right Now

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock might soar as investors bet on the company's cutting-edge technology through its...

CRSP : 41.22 (+0.12%)
MRNA : 32.66 (+0.65%)
Merck Loses Almost $52B in 6 Months: How to Play MRK Stock

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market valueThe numerous challenges plaguing the company resulted in the dilution of the stock’s market...

MRK : 93.11 (-1.71%)
SMMT : 19.75 (+1.59%)
MRNA : 32.66 (+0.65%)
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

MYGN : 10.01 (+1.01%)
VRTX : 503.20 (-1.37%)
BMRN : 71.24 (-0.50%)
GILD : 107.08 (+1.14%)
MRNA : 32.66 (+0.65%)
Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25.Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales performance...

MRK : 93.11 (-1.71%)
MRNA : 32.66 (+0.65%)
GSK : 39.24 (-0.43%)
PFE : 26.28 (+0.34%)
Moderna Stock: Is MRNA Underperforming the Healthcare Sector?

As Moderna has underperformed its broader sector recently, analysts remain cautious about the stock’s prospects.

XLV : 146.60 (-0.28%)
NVAX : 7.60 (-1.55%)
MRNA : 32.66 (+0.65%)
PFE : 26.28 (+0.34%)
BNTX : 95.38 (-0.88%)
MarketBeat Week in Review – 03/10 - 03/14

Stocks continued to be under pressure on concerns over tariffs and growing inflation concerns, but history shows that corrections can set up opportunities

NVDA : 117.70 (-0.70%)
META : 596.25 (+1.75%)
TSLA : 248.71 (+5.27%)
INTC : 24.26 (+1.25%)
WBA : 11.10 (-0.18%)
NU : 11.59 (+1.67%)
MU : 94.72 (-8.04%)
RKLB : 18.94 (+2.21%)
MRNA : 32.66 (+0.65%)
IOT : 40.16 (+1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 34.40
2nd Resistance Point 33.60
1st Resistance Point 33.13
Last Price 32.66
1st Support Level 31.86
2nd Support Level 31.05
3rd Support Level 30.58

See More

52-Week High 170.47
Fibonacci 61.8% 116.52
Fibonacci 50% 99.86
Fibonacci 38.2% 83.20
Last Price 32.66
52-Week Low 29.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar